Home › NDC Lookup › RxCUI directory › RxCUI 897590

24 HR verapamil hydrochloride 200 MG Extended Release Oral Capsule — RxCUI 897590

RxNorm drug concept · Semantic clinical drug
RxCUI 897590 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI897590
Official name24 HR verapamil hydrochloride 200 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asverapamil HCl 200 MG 24HR Extended Release Oral Capsule
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)645 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Verapamil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Verapamil tablets treat angina, certain fast heart rhythms and high blood pressure. Extended-release forms are used for high blood pressure. The injectio...
  • Extended-release tablets are taken with food in the morning. The PM capsules are taken at bedtime. Swallow capsules whole, or sprinkle the entire contents on applesauce. Never crus...
  • How should I take my extended-release verapamil?
  • Constipation is the most common, along with headache, dizziness and ankle swelling. Tell your doctor if they bother you. Call right away for fainting, a very slow heartbeat, shortn...
📖 Read our full Verapamil guide →

🕸️ Concept Web — How 24 HR verapamil hydrochloride 200 MG Extended Re... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR verapamil hydrochloride 200 MG Extended Release Oral Capsule RxCUI 897590

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Verapamil 11170
    • Verapamil hydrochloride 203138
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Verelan 220778
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Verapamil Extended Release Oral Capsule 375337
    • Verapamil hydrochloride Extended Release Oral Capsule 2647487
    • Verapamil Oral Product 1160512
    • Verapamil Pill 1160513
    • Verapamil hydrochloride Oral Product 2660958
    • Verapamil hydrochloride Pill 2659127
    • Verapamil Extended Release Oral Capsule [Verelan] 367136
    • Verapamil hydrochloride Extended Release Oral Capsule [Verelan] 2658575
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Verapamil hydrochloride 200 MG 897589
    • 24 HR verapamil hydrochloride 200 MG Extended Release Oral Capsule [Verelan] 897592
    • Verapamil hydrochloride 200 MG [Verelan] 897591

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Verapamil hydrochloride 200 MG SCDC · 897589
  • Verapamil Extended Release Oral Capsule SCDF · 375337
  • Verapamil hydrochloride Extended Release Oral Capsule SCDFP · 2647487
  • Verapamil Oral Product SCDG · 1160512
  • Verapamil Pill SCDG · 1160513
  • Verapamil hydrochloride Oral Product SCDGP · 2660958
  • Verapamil hydrochloride Pill SCDGP · 2659127

Brand-Name Concepts

  • 24 HR verapamil hydrochloride 200 MG Extended Release Oral Capsule [Verelan] SBD · 897592
  • Verapamil hydrochloride 200 MG [Verelan] SBDC · 897591
  • Verapamil Extended Release Oral Capsule [Verelan] SBDF · 367136
  • Verapamil hydrochloride Extended Release Oral Capsule [Verelan] SBDFP · 2658575
  • Verelan Oral Product SBDG · 1187891
  • Verelan Pill SBDG · 1187892
  • Verelan BN · 220778

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 897590 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52536-0485-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52536-485-37) Verapamil Hydrochloride Wilshire Pharmaceuticals, Inc. 2024-11-26
52536-0486-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52536-486-37) Verapamil Hydrochloride Wilshire Pharmaceuticals, Inc. 2024-11-26
52536-0487-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52536-487-37) Verapamil Hydrochloride Wilshire Pharmaceuticals, Inc. 2024-11-26
Observed labelers: Wilshire Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.